Earnings NewsHealthcareCoLucid Pharmaceuticals reports Q3 resultsNov. 09, 2016 8:13 AM ETCoLucid Pharmaceuticals (CLCD) StockBy: Niloofer Shaikh, SA News Editor CoLucid Pharmaceuticals (NASDAQ:CLCD): Q3 EPS of -$0.79. Cash and cash equivalents of $83.54M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgCLCD--CoLucid PharmaceuticalsTrending AnalysisTrending News